
OptimizeRx fell 55.1% from $14.79 to $6.64, behind the S&P 500's +11.2%. Its worst day was May 13 (−22.5%), and its low came Jun 23 at $4.54.
Nov 17, 2025 – Nov 16, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
OptimizeRx closed at its highest level of the year, 4.1% above where the year started.
+0.7% · S&P 500 +0.9%
EPS of $0.51 beat the $0.18 estimate on $32.2M revenue (est. $31.2M); FY revenue guidance of $109.0M–$114.0M against the $122.1M consensus.
Story events cover the past 12 months · Times ET
−10.5% · S&P 500 −1.3%
EPS of $0.14 beat the $-0.02 estimate on $19.8M revenue (est. $18.4M); FY revenue guidance of $95.0M–$100.0M against the $111.6M consensus.
−22.5%, the year's worst day, on 2M shares, the year's heaviest volume · S&P 500 +0.6%
OptimizeRx closed at its lowest level of the year, 69.3% below where the year started.
−3.0% · S&P 500 −1.5%
EPS of $0.16 beat the $0.09 estimate on $20.5M revenue (est. $20.3M); FY revenue guidance of $95.0M–$100.0M against the $97.5M consensus.
+24.7%, the year's best day · S&P 500 +0.7%
EPS of $0.20 beat the $0.14 estimate on $21.6M revenue (est. $21.2M); FY revenue guidance of $87.0M–$93.0M against the $96.2M consensus.
−0.9% · S&P 500 −0.4%
Where it ended: a close of $6.64 on Nov 16, 2026. Up next: Q4 2026 earnings on Mar 4, 2027 (EPS est. $0.22, revenue est. $22.7M).
Nothing in the past 12 months.
All OPRX dividend historyReplay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for OPRX and SPY from Benzinga historical bars. Not investment advice.